ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRY ARS PHARMACEUTICALS INC

盘前交易 07-11 06:10:41 EDT

17.98

+0.08

+0.45%

最高18.05	最低17.29	成交量143.11万
今开17.93	昨收17.90	日振幅4.26%
总市值17.66亿	流通市值9.45亿	总股本9,821万
成交额2,564万	换手率2.72%	流通股本5,254万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":17.98,"timestamp":1752177600000,"preClose":17.9,"halted":0,"volume":1431052,"delay":0,"floatShares":52543430,"shares":98213561,"eps":-0.160792,"marketStatus":"盘前交易","change":0.08,"latestTime":"07-11 06:10:41 EDT","open":17.93,"high":18.05,"low":17.2875,"amount":25635536.38604,"amplitude":0.042598,"askPrice":19.5,"askSize":500,"bidPrice":15.55,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.160792,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752240600000},"marketStatusCode":1,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":17.98,"postHourTrading":{"tag":"盘后","latestPrice":17.98,"preClose":17.98,"latestTime":"19:56 EDT","volume":12742,"amount":229103.272,"timestamp":1752191797413},"volumeRatio":1.1303526492682534,"impliedVol":0.4662,"impliedVolPercentile":0.1205},"requestUrl":"/m/hq/s/SPRY","defaultTab":"news","newsList":[{"id":"2550659198","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659198?lang=zh_cn&edition=full","pubTime":"2025-07-09 23:03","pubTimestamp":1752073380,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日23时03分，Ars Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.01%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为1194.35%、717.57%、536.32%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.，振幅分别为202.99%、112.02%、72.12%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230301979fca8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230301979fca8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2549553202","title":"Ars Pharmaceuticals, Inc.盘中异动 急速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549553202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549553202?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:24","pubTimestamp":1751898245,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时24分，Ars Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.18%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为3624.75%、1065.90%、802.62%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为244.54%、93.67%、84.08%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707222405a69b2d9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707222405a69b2d9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2548000974","title":"Ars Pharmaceuticals, Inc.盘中异动 快速下跌5.04%报16.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548000974?lang=zh_cn&edition=full","pubTime":"2025-07-01 22:11","pubTimestamp":1751379111,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日22时11分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.04%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Lixte Biotechnology Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Atai Life Sciences N.V.涨幅较大，Oragenics Inc.、Soligenix, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1716.19%、1108.35%、120.47%，振幅较大的相关个股有Lixte Biotechnology Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Neurogene Inc.，振幅分别为56.35%、43.82%、33.99%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701221151a4c92b6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701221151a4c92b6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2547097769","title":"Ars Pharmaceuticals, Inc.盘中异动 快速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547097769?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:44","pubTimestamp":1751291045,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时44分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.14%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2257.17%、134.30%、75.37%，振幅较大的相关个股有Artelo Biosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Eyenovia, Inc.，振幅分别为79.51%、34.23%、26.93%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021440695315456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021440695315456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2546756394","title":"Ars Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546756394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546756394?lang=zh_cn&edition=full","pubTime":"2025-06-27 03:06","pubTimestamp":1750964817,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日03时06分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.10%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Aspire Biopharma Holdings, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1456.73%、311.83%、223.68%，振幅较大的相关个股有Vor Biopharma Inc.、Moolec Science Sa C/Wts 、Adial Pharmaceuticals, Inc，振幅分别为98.85%、61.67%、49.88%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627030657952cfee9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627030657952cfee9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2545392752","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545392752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545392752?lang=zh_cn&edition=full","pubTime":"2025-06-24 23:15","pubTimestamp":1750778138,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时15分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.01%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.55%。其相关个股中，内克塔治疗、Apollomics Inc C/Wts 01/04/2028 、Eyenovia, Inc.涨幅较大，Nucana Plc、Adial Pharmaceuticals, Inc、Eyenovia, Inc.较为活跃，换手率分别为856.72%、522.10%、465.91%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Eyenovia, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为176.26%、70.80%、69.60%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624231539a71b784a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624231539a71b784a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2543639200","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.21%报15.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543639200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543639200?lang=zh_cn&edition=full","pubTime":"2025-06-14 00:54","pubTimestamp":1749833664,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日00时54分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.21%。截至发稿，该股报15.15美元/股，成交量36.7712万股，换手率0.37%，振幅6.74%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614005425a707eeb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614005425a707eeb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2541861237","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541861237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541861237?lang=zh_cn&edition=full","pubTime":"2025-06-06 23:54","pubTimestamp":1749225245,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日23时54分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.02%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Eyenovia, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为2448.32%、796.12%、86.67%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Klotho Neurosciences, Inc.、Eyenovia, Inc.，振幅分别为61.85%、58.69%、41.40%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606235405a49d1a00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606235405a49d1a00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2541095201","title":"Ars Pharmaceuticals, Inc.盘中异动 下午盘急速下挫5.02%报13.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541095201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541095201?lang=zh_cn&edition=full","pubTime":"2025-06-05 03:20","pubTimestamp":1749064818,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日03时20分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.02%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Cellectar Biosciences, Inc.、Hoth Therapeutics, Inc.、Lyell Immunopharma, Inc.涨幅较大，Nucana Plc、Cellectar Biosciences, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1697.22%、1313.35%、621.61%，振幅较大的相关个股有Cellectar Biosciences, Inc.、Hoth Therapeutics, Inc.、Lyell Immunopharma, Inc.，振幅分别为106.81%、82.62%、67.58%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605032019a6faa520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605032019a6faa520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2539757892","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.29%报14.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539757892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539757892?lang=zh_cn&edition=full","pubTime":"2025-05-30 22:57","pubTimestamp":1748617046,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日22时57分，Ars Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.29%。截至发稿，该股报14.67美元/股，成交量25.4109万股，换手率0.26%，振幅4.39%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.95%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530225726a493031a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530225726a493031a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2537595981","title":"Ars Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537595981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537595981?lang=zh_cn&edition=full","pubTime":"2025-05-24 02:06","pubTimestamp":1748023563,"startTime":"0","endTime":"0","summary":"北京时间2025年05月24日02时06分，Ars Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.30%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Polyrizon Ltd.、Imunon, Inc.、Nucana Plc较为活跃，换手率分别为4436.63%、2299.95%、1112.46%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.，振幅分别为208.33%、170.40%、101.08%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524020604a489fddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524020604a489fddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2537750923","title":"Ars Pharmaceuticals, Inc.2025财年第一财季实现净利润-33.94百万美元，同比减少229.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537750923","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537750923?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:00","pubTimestamp":1747929623,"startTime":"0","endTime":"0","summary":"5月23日，Ars Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第一财季净利润为-33.94百万美元，同比减少229.83%；其中营业收入为7.97百万美元，每股基本收益为-0.35美元。从资产负债表来看，Ars Pharmaceuticals, Inc.总负债98.34百万美元，其中短期债务73000.00美元，资产负债比为0.04，流动比率为0.12。机构评级：截至2025年5月23日，当前有5家机构对Ars Pharmaceuticals, Inc.目标价做出预测，其中目标均价为31.60美元，其中最低目标价为26.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000049a4887653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000049a4887653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY"],"gpt_icon":0},{"id":"2536637520","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536637520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536637520?lang=zh_cn&edition=full","pubTime":"2025-05-20 03:56","pubTimestamp":1747684590,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日03时56分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.00%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Armata Pharmaceuticals, Inc.涨幅较大，Protagenic Therapeutics, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为16341.93%、10988.37%、2861.60%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为894.34%、262.71%、138.78%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520035631975ea3bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520035631975ea3bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1194781826","title":"异动解读 | 季报超预期，ARS制药盘中大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194781826","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194781826?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:36","pubTimestamp":1747402582,"startTime":"0","endTime":"0","summary":"美国生物制药公司ARS Pharmaceuticals Inc周五盘中表现强劲，股价大涨5.17%，引发市场广泛关注。根据ARS制药公布的截至3月31日的季度报告，公司调整后每股亏损35美分，符合分析师预期。除了财报利好，分析师对ARS制药的前景持积极态度也是推动股价上涨的重要因素。值得一提的是，ARS制药股价本季度已上涨6.1%，今年迄今为止累计上涨26.5%，显示出良好的市场表现。这种持续的正面势头进一步刺激了投资者的买入热情，推动盘中股价出现大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0},{"id":"1194536259","title":"异动解读 | 季报超预期，ARS制药盘中大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194536259","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194536259?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:36","pubTimestamp":1747402580,"startTime":"0","endTime":"0","summary":"美国生物制药公司ARS Pharmaceuticals Inc周五盘中表现强劲，股价大涨5.17%，引发市场广泛关注。根据ARS制药公布的截至3月31日的季度报告，公司调整后每股亏损35美分，符合分析师预期。除了财报利好，分析师对ARS制药的前景持积极态度也是推动股价上涨的重要因素。值得一提的是，ARS制药股价本季度已上涨6.1%，今年迄今为止累计上涨26.5%，显示出良好的市场表现。这种持续的正面势头进一步刺激了投资者的买入热情，导致盘中股价出现大幅上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0},{"id":"2535313236","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.21%报12.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535313236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535313236?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:35","pubTimestamp":1747402549,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时35分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.21%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Inozyme Pharma, Inc.、Affimed N.V.、Pasithea Therapeutics Corp.涨幅较大，Polyrizon Ltd.、Affimed N.V.、Nucana Plc较为活跃，换手率分别为1217.49%、844.96%、658.73%，振幅较大的相关个股有Affimed N.V.、Pasithea Therapeutics Corp.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为69.68%、31.37%、22.50%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621355094f90fa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621355094f90fa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1102732161","title":"异动解读 | ARS制药季报超预期，夜盘股价暴涨11.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102732161","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102732161?lang=zh_cn&edition=full","pubTime":"2025-05-16 14:53","pubTimestamp":1747378396,"startTime":"0","endTime":"0","summary":"美国生物制药公司ARS Pharmaceuticals Inc在夜盘交易中股价暴涨11.57%，引发市场广泛关注。根据ARS制药公布的截至3月31日的季度报告，公司调整后每股亏损35美分，符合分析师预期。更值得注意的是，公司季度营收达到797万美元，超过市场预期的748万美元。除了亮眼的财报数据外，分析师对ARS制药的前景持积极态度也进一步支撑了股价走强。值得一提的是，ARS制药股价本季度已上涨6.1%，今年迄今为止累计上涨26.5%，显示出持续良好的市场表现。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0},{"id":"1178137277","title":"异动解读 | 季报超预期，ARS制药夜盘大涨11.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178137277","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178137277?lang=zh_cn&edition=full","pubTime":"2025-05-16 14:46","pubTimestamp":1747377987,"startTime":"0","endTime":"0","summary":"美国生物制药公司ARS Pharmaceuticals Inc在夜盘交易中表现强劲，股价大涨11.57%，引发市场广泛关注。根据ARS制药公布的截至3月31日的季度报告，公司调整后每股亏损35美分，符合分析师预期。除了财报利好，分析师对ARS制药的前景持积极态度也是推动股价上涨的重要因素。值得一提的是，ARS制药股价本季度已上涨6.1%，今年迄今为止累计上涨26.5%，显示出良好的市场表现。这种持续的正面势头进一步刺激了投资者的买入热情，导致夜盘交易中股价出现大幅上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0},{"id":"1170026771","title":"异动解读 | ARS制药季报超预期，夜盘股价暴涨11.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170026771","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170026771?lang=zh_cn&edition=full","pubTime":"2025-05-15 09:50","pubTimestamp":1747273854,"startTime":"0","endTime":"0","summary":"美国生物制药公司ARS Pharmaceuticals Inc在夜盘交易中股价暴涨11.57%，引发市场广泛关注。根据ARS制药公布的截至3月31日的季度报告，公司调整后每股亏损35美分，符合分析师预期。更值得注意的是，公司季度营收达到797万美元，超过市场预期的748万美元。除了亮眼的财报数据外，分析师对ARS制药的前景持积极态度也进一步支撑了股价走强。值得一提的是，ARS制药股价本季度已上涨6.1%，今年迄今为止累计上涨26.5%，显示出持续良好的市场表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0},{"id":"1115917041","title":"异动解读 | 季报超预期，ARS制药夜盘大涨11.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115917041","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115917041?lang=zh_cn&edition=full","pubTime":"2025-05-15 09:50","pubTimestamp":1747273849,"startTime":"0","endTime":"0","summary":"美国生物制药公司ARS Pharmaceuticals Inc在夜盘交易中表现强劲，股价大涨11.57%，引发市场广泛关注。根据ARS制药公布的截至3月31日的季度报告，公司调整后每股亏损35美分，符合分析师预期。除了财报利好，分析师对ARS制药的前景持积极态度也是推动股价上涨的重要因素。值得一提的是，ARS制药股价本季度已上涨6.1%，今年迄今为止累计上涨26.5%，显示出良好的市场表现。这种持续的正面势头进一步刺激了投资者的买入热情，导致夜盘交易中股价出现大幅上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ars-pharma.com","stockEarnings":[{"period":"1week","weight":0.0884},{"period":"1month","weight":0.224},{"period":"3month","weight":0.2797},{"period":"6month","weight":0.5996},{"period":"1year","weight":0.7189},{"period":"ytd","weight":0.7043}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ARS Pharmaceuticals, Inc.于2016年1月4日根据特拉华州法律成立。该公司是一家生物制药公司，专注于开发新型、可能是一流的候选产品，neffy用于I型过敏反应的紧急治疗，包括过敏反应。neffy是一种肾上腺素的专有组合物，具有一种名为Intravail的创新吸收增强剂，允许neffy以小剂量、易于携带、易于使用、快速给药和可靠的鼻喷雾剂提供注射般的肾上腺素吸收。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.029887},{"month":2,"riseRate":0.6,"avgChangeRate":0.08605},{"month":3,"riseRate":0.4,"avgChangeRate":-0.024933},{"month":4,"riseRate":0.2,"avgChangeRate":-0.083829},{"month":5,"riseRate":0.8,"avgChangeRate":0.021109},{"month":6,"riseRate":0.6,"avgChangeRate":0.093442},{"month":7,"riseRate":0.8,"avgChangeRate":0.120388},{"month":8,"riseRate":0.5,"avgChangeRate":-0.015111},{"month":9,"riseRate":0.25,"avgChangeRate":-0.231382},{"month":10,"riseRate":0.5,"avgChangeRate":0.000594},{"month":11,"riseRate":0.25,"avgChangeRate":0.038319},{"month":12,"riseRate":0.5,"avgChangeRate":0.045103}],"exchange":"NASDAQ","name":"ARS PHARMACEUTICALS INC","nameEN":"ARS PHARMACEUTICALS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ARS PHARMACEUTICALS INC(SPRY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ARS PHARMACEUTICALS INC,SPRY,ARS PHARMACEUTICALS INC股票,ARS PHARMACEUTICALS INC股票老虎,ARS PHARMACEUTICALS INC股票老虎国际,ARS PHARMACEUTICALS INC行情,ARS PHARMACEUTICALS INC股票行情,ARS PHARMACEUTICALS INC股价,ARS PHARMACEUTICALS INC股市,ARS PHARMACEUTICALS INC股票价格,ARS PHARMACEUTICALS INC股票交易,ARS PHARMACEUTICALS INC股票购买,ARS PHARMACEUTICALS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ARS PHARMACEUTICALS INC(SPRY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况